N
IRWD icon

Nuveen’s Ironwood Pharmaceuticals IRWD Stock Holding History

Nuveen’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$819K Buy
233,412
+93,925
+67% +$385K ﹤0.01% 2666
2025
Q4 		$470K Buy
+139,487
New +$362K ﹤0.01% 2901
2025
Q2 		– Sell
-471,361
Closed -$693K – 3331
2025
Q1 		$693K Buy
471,361
+66,007
+16% +$157K ﹤0.01% 2790
2024
Q4 		$1.8M Hold
405,354
– – ﹤0.01% 2429
2024
Q3 		$1.67M Sell
405,354
-54,087
-12% -$291K ﹤0.01% 2505
2024
Q2 		$3M Sell
459,441
-1,383,802
-75% -$9.79M ﹤0.01% 2187
2024
Q1 		$16.1M Buy
1,843,243
+6,918
+0.4% +$83.9K ﹤0.01% 1311
2023
Q4 		$21M Buy
1,836,325
+706,218
+62% +$6.99M 0.01% 1129
2023
Q3 		$10.9M Sell
1,130,107
-582,623
-34% -$5.71M ﹤0.01% 1428
2023
Q2 		$18.2M Buy
1,712,730
+107,634
+7% +$1.16M 0.01% 1126
2023
Q1 		$16.9M Sell
1,605,096
-204,093
-11% -$2.29M 0.01% 1157
2022
Q4 		$22.4M Buy
1,809,189
+97,790
+6% +$1.11M 0.01% 960
2022
Q3 		$17.7M Sell
1,711,399
-536,357
-24% -$6.08M 0.01% 1101
2022
Q2 		$25.9M Buy
2,247,756
+28,183
+1% +$332K 0.01% 867
2022
Q1 		$27.4M Buy
2,219,573
+115,934
+6% +$1.33M 0.01% 993
2021
Q4 		$23.2M Sell
2,103,639
-192,522
-8% -$2.36M 0.01% 1131
2021
Q3 		$28.4M Sell
2,296,161
-11,444
-0.5% -$148K 0.01% 1028
2021
Q2 		$29.7M Buy
2,307,605
+910,801
+65% +$10.4M 0.01% 1081
2021
Q1 		$15.6M Buy
1,396,804
+527,067
+61% +$5.57M 0.01% 1502
2020
Q4 		$9.91M Sell
869,737
-220,206
-20% -$2.41M ﹤0.01% 1718
2020
Q3 		$9.8M Sell
1,089,943
-400,350
-27% -$3.98M ﹤0.01% 1540
2020
Q2 		$15.4M Buy
1,490,293
+500,309
+51% +$5.12M 0.01% 1209
2020
Q1 		$9.99M Buy
989,984
+387,960
+64% +$4.56M ﹤0.01% 1294
2019
Q4 		$8.01M Sell
602,024
-415,725
-41% -$4.58M ﹤0.01% 1724
2019
Q3 		$8.74M Buy
1,017,749
+92,092
+10% +$895K ﹤0.01% 1655
2019
Q2 		$10.1M Buy
+925,657
New +$10.4M ﹤0.01% 1605

Other funds holding IRWD

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Nuveen's IRWD Position: Q1 2026 in Review

Nuveen increased its Ironwood Pharmaceuticals (IRWD) stake by 67% in Q1 2026, buying an estimated $385K and bringing the position to 233,412 shares worth $819K. The position accounts for ﹤0.01% of the portfolio, ranked #2666.

Nuveen first reported a position in IRWD in Q2 2019 and has held it in 26 quarters since. The position peaked at $29.7M in Q2 2021. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

  • Nuveen held 233,412 shares of Ironwood Pharmaceuticals worth $819K as of Q1 2026.
  • Nuveen bought 93,925 Ironwood Pharmaceuticals shares in Q1 2026, an estimated $385K.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Nuveen's portfolio in Q1 2026, its #2666 holding.
  • Nuveen first reported a position in Ironwood Pharmaceuticals in Q2 2019 and has held it in 26 quarters since.
  • Nuveen's Ironwood Pharmaceuticals position peaked at $29.7M in Q2 2021.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.